rs2228063
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_000067.3(CA2):āc.754A>Gā(p.Asn252Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00471 in 1,613,926 control chromosomes in the GnomAD database, including 338 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N252S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000067.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CA2 | NM_000067.3 | c.754A>G | p.Asn252Asp | missense_variant | 7/7 | ENST00000285379.10 | |
CA2 | NM_001293675.2 | c.451A>G | p.Asn151Asp | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CA2 | ENST00000285379.10 | c.754A>G | p.Asn252Asp | missense_variant | 7/7 | 1 | NM_000067.3 | P1 | |
CA2 | ENST00000520127.5 | c.*341A>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0260 AC: 3957AN: 152178Hom.: 184 Cov.: 32
GnomAD3 exomes AF: 0.00680 AC: 1708AN: 251198Hom.: 72 AF XY: 0.00485 AC XY: 658AN XY: 135748
GnomAD4 exome AF: 0.00249 AC: 3642AN: 1461630Hom.: 153 Cov.: 30 AF XY: 0.00213 AC XY: 1549AN XY: 727112
GnomAD4 genome AF: 0.0260 AC: 3963AN: 152296Hom.: 185 Cov.: 32 AF XY: 0.0253 AC XY: 1882AN XY: 74480
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 27, 2020 | This variant is associated with the following publications: (PMID: 31690045) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Osteopetrosis with renal tubular acidosis Benign:3
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 30, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
CARBONIC ANHYDRASE II VARIANT Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 25, 1972 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at